Phathom Pharmaceuticals, Inc.
PHAT
$4.41
$0.194.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M |
| Total Depreciation and Amortization | 193.00K | 191.00K | 197.00K | 214.00K | 185.00K |
| Total Amortization of Deferred Charges | 629.00K | 346.00K | 743.00K | 474.00K | 566.00K |
| Total Other Non-Cash Items | 19.21M | 20.08M | 20.41M | 20.17M | 34.35M |
| Change in Net Operating Assets | -9.04M | 1.39M | -626.00K | -7.02M | 676.00K |
| Cash from Operations | -63.46M | -63.57M | -70.72M | -69.02M | -43.80M |
| Capital Expenditure | -5.00K | -44.00K | -46.00K | -40.00K | -475.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.00K | -44.00K | -46.00K | -40.00K | -475.00K |
| Total Debt Issued | 24.75M | 0.00 | 24.75M | 9.90M | 211.99M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.30M | 122.06M | 21.00K | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.05M | 122.06M | 24.77M | 9.90M | 211.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.42M | 58.44M | -46.00M | -59.16M | 167.72M |
